A mixed approach for proving non-inferiority in clinical trials with binary endpoints

被引:21
|
作者
Rousson, Valentin [1 ]
Seifert, Burkhardt [2 ]
机构
[1] Univ Lausanne, Inst Social & Prevent Med, Stat Unit, CH-1005 Lausanne, Switzerland
[2] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8001 Zurich, Switzerland
关键词
active control; non-inferiofity margin; odds-ratio; difference of proportions; sample size calculation; test for non-inferiority;
D O I
10.1002/bimj.200710410
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
When a new treatment is compared to an established one in a randomized clinical trial, it is standard practice to statistically test for non-inferiority rather than for superiority. When the endpoint is binary, one usually compares two treatments using either an odds-ratio or a difference of proportions. In this paper, we propose a mixed approach which uses both concepts. One first defines the non-inferiority margin using an odds-ratio and one ultimately proves non-inferiority statistically using a difference of proportions. The mixed approach is shown to be more powerful than the conventional odds-ratio approach when the efficacy of the established treatment is known (with good precision) and high (e.g. with more than 56% of success). The gain of power achieved may lead in turn to a substantial reduction in the sample size needed to prove non-inferiority. The mixed approach can be generalized to ordinal endpoints.
引用
收藏
页码:190 / 204
页数:15
相关论文
共 50 条
  • [31] Two New Covariate Adjustment Methods for Non-Inferiority Assessment of Binary Clinical Trials Data
    Hou, Yan
    Ding, Victoria
    Li, Kang
    Zhou, Xiao-Hua
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2011, 21 (01) : 77 - 93
  • [32] Choosing and changing the analysis scale in non-inferiority trials with a binary outcome
    Li, Zhong
    Quartagno, Matteo
    Bohringer, Stefan
    van Geloven, Nan
    CLINICAL TRIALS, 2022, 19 (01) : 14 - 21
  • [33] The Non-Inferiority Complex: What Do Non-Inferiority Trials Tell Us?
    Assimon, Magdalene M.
    Cutter, Gary R.
    Bargman, Joanne M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (04): : 674 - 676
  • [34] Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints
    Song, James X.
    COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2009, 53 (04) : 1201 - 1207
  • [35] Introduction to randomized trials: Non-inferiority trials
    Simon, E. -G.
    Fouche, C. -J.
    Perrotin, F.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2012, 40 (09): : 554 - 556
  • [36] Re-Formulating Non-inferiority Trials as Superiority Trials: The Case of Binary Outcomes
    Durkalski, Valerie L.
    Berger, Vance W.
    BIOMETRICAL JOURNAL, 2009, 51 (01) : 185 - 192
  • [37] The use of the win odds in the design of non-inferiority clinical trials
    Peng, Lei
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (05) : 941 - 946
  • [38] Non-inferiority clinical trials: importance and applications in health sciences
    Honorio, Heitor Marques
    Wang, Linda
    Rios, Daniela
    BRAZILIAN ORAL RESEARCH, 2020, 34
  • [39] Subgroup discovery in non-inferiority trials
    Fazzari, Melissa J.
    Kim, Mimi Y.
    STATISTICS IN MEDICINE, 2021, 40 (24) : 5174 - 5187
  • [40] Equivalence and Non-inferiority Trials of CAM
    Ernst, Edzard
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2004, 1 (01) : 9 - 10